| Price | 6.95p on 12-05-2026 at 17:15:09 |
|---|---|
| Change | -0.05p -0.71% |
| Buy | 7.10p |
| Sell | 6.80p |
| Last Trade: | Unknown 50,000.00 at 6.95p |
| Day's Volume: | 1,081,007 |
| Last Close: | 6.95p |
| Open: | 7.00p |
| ISIN: | GB00BYV81293 |
| Day's Range | 6.95p - 7.00p |
| 52wk Range: | 2.25p - 12.35p |
| Market Capitalisation: | £74.26m |
| VWAP: | 6.931298p |
| Shares in Issue: | 1.07b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Shield Thera (STX) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 50,000 | 6.95p | OTC Trade |
17:07:44 - 12-May-26 |
| Sell* | 14,487 | 6.875p | Ordinary |
16:28:11 - 12-May-26 |
| Sell* | 1,207 | 6.80p | SI Trade |
16:21:03 - 12-May-26 |
| Sell* | 17,398 | 6.8973p | Ordinary |
16:12:25 - 12-May-26 |
| Buy* | 51,482 | 7.00p | Ordinary |
16:09:33 - 12-May-26 |
| Sell* | 8,519 | 6.81p | Ordinary |
16:06:01 - 12-May-26 |
| Sell* | 10,000 | 6.925p | Ordinary |
16:03:59 - 12-May-26 |
| Sell* | 20,815 | 6.81p | Ordinary |
15:20:50 - 12-May-26 |
| Buy* | 98 | 7.10p | SI Trade |
15:16:34 - 12-May-26 |
| Buy* | 210 | 7.05p | Ordinary |
15:10:04 - 12-May-26 |
Shield Thera (STX) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 5th May 2026 7:00 am | RNS | Grant of Share Options |
| 1st May 2026 7:00 am | RNS | Q1 2026 Trading Update |
| 30th Apr 2026 7:01 am | RNS | Total Voting Rights |
| 27th Apr 2026 7:00 am | RNS | Enrollment in Phase II Clinical Trial for ACCRUFeR |
| 9th Apr 2026 12:30 pm | RNS | Audited results for year ended 31 December 2025 |
| 1st Apr 2026 9:22 am | RNS-R | Publication of Report, Reinforcing FDA Approval |
| 31st Mar 2026 7:03 am | RNS | Total Voting Rights |
| 31st Mar 2026 7:00 am | RNS | EMA approves extension - to include adolescents |
| 3rd Mar 2026 7:00 am | RNS | Chinese NMPA Accepts MAA Submission for ACCRUFeR® |
| 27th Feb 2026 7:00 am | RNS | Total Voting Rights |
